title: Hypothalamic sites of catecholamine inhibition of luteinizing hormone in the anestrous ewe.
abstract: Norepinephrine (NE) and dopamine (DA) actively inhibit the release of LH in anestrous ewes. This can be detected as an increase in LH pulse frequency following i.v. injection of NE and DA antagonists. The objective of this study was to determine the sites of these inhibitory actions in the ovine hypothalamus by using local administrations of the NE antagonist, phenoxybenzamine (PBZ), or the DA antagonist, pimozide (PIM), into specific hypothalamic areas. Each neurotransmitter antagonist was administered via a chronically implanted steel guide tube into either the preoptic area (POA), retrochiasmatic area (RCh), or the median eminence region (ME). Blood samples were taken every 15 min for 2 h before and 4 h during implantation of these drugs and were analyzed for LH and prolactin by RIA. Control (no treatment) samples were obtained similarly from the same animals on another day. Placement of PBZ into the POA significantly increased LH pulse frequency and mean LH concentrations over control values whereas PIM did not. In contrast, PIM significantly increased LH pulse frequency and mean LH concentrations when placed in the ME or in the RCh, but PBZ did not. No effects of PIM on prolactin concentrations were detected. These results suggest that an NE neural system operates in the POA and that a DA system acts in the medial basal hypothalamus (RCh or ME) to suppress GnRH pulse frequency in the ovary-intact anestrous ewe.
authors.affiliation: Department of Physiology, West Virginia University Health Sciences Center, North Morgantown 26506.
authors.forename: R L
authors.initials: RL
authors.lastname: Havern
authors.forename: C S
authors.initials: CS
authors.lastname: Whisnant
authors.forename: R L
authors.initials: RL
authors.lastname: Goodman
mesh_terms: D000780:Anestrus / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000502:physiology*; D005260:Female; D007031:Hypothalamus / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology; D007986:Luteinizing Hormone / Q000378:metabolism*; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors / Q000502:physiology; D010643:Phenoxybenzamine / Q000008:administration & dosage; D010868:Pimozide / Q000008:administration & dosage; D012756:Sheep
chemical_list: D002395:Catecholamines; D018377:Neurotransmitter Agents; D010643:Phenoxybenzamine; D010868:Pimozide; D007986:Luteinizing Hormone